Skip to main content

View full-text article in PMC

. 2015 Jan 8;15:7. doi: 10.1186/s12879-014-0744-4

Table 1.

Solicited adverse events after vaccinations at each dose in the study subjects (safety population)

	Group (n)	No. (%) of subjects		p -value*
	Group (n)	AE	no AE	p -value*
Total	KD-287 (102)	87 (85.29)	15 (14.71)	0.050
Total	JEV-GCC (102)	77 (75.49)	25 (24.51)	0.050
After 1^st Vaccination	KD-287 (102)	65 (63.73)	37 (36.27)	0.118
After 1^st Vaccination	JEV-GCC (102)	54 (52.94)	48 (47.06)	0.118
After 2^nd Vaccination	KD-287 (102)	45 (44.12)	57 (55.88)	0.900
After 2^nd Vaccination	JEV-GCC (100)	45 (45.00)	55 (55.00)	0.900
After 3^rd Vaccination	KD-287 (100)	46 (46.00)	54 (54.00)	0.394
After 3^rd Vaccination	JEV-GCC (96)	50 (52.08)	46 (47.92)	0.394

AE, adverse event.

*The p-value was calculated using the chi-square test.